1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA - CAS 2830282-77-2

1-Palmitoyl-d9-2-hydroxy-sn-glycero-3-PA (1-palmitoyl-d9LPA) serves as an internal standard for the quantification of 1-palmitoyl LPA using GC- or LC-MS. This compound, an analog of LPA with palmitic acid at the sn-1 position, activates reporter gene expression in PC12 cells fitted with human lysophosphatidic acid receptor 4 (LPA4) at 0.01 to 10 μM concentrations. Additionally, 1-palmitoyl LPA prompts aggregation in isolated human platelets within the 12-300 μM range, a process reversible by prostaglandin E1 (PGE1), theophylline, or EDTA. It also interacts with calcium and magnesium to boost the efficacy of ampicillin, piperacillin, and ceftazidime against P. aeruginosa strains from cystic fibrosis patients.

Others

Others

2830282-77-2

C19H30D9O7P

419.54

C(OC[C@H](COP(=O)(O)O)O)(CCCCCCCCCCCC(C(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H])([2H])[2H])=O

-20°C

Ice Packs

Isotope products